Avalon GloboCare Faces Delisting Notice
Ticker: ALBT · Form: 8-K · Filed: Nov 1, 2024 · CIK: 1630212
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
Related Tickers: AVCO
TL;DR
AVCO got a delisting warning, might be kicked off the exchange.
AI Summary
Avalon GloboCare Corp. filed an 8-K on November 1, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of October 29, 2024. The company is incorporated in Delaware and its principal executive offices are located in Freehold, NJ.
Why It Matters
This filing indicates potential issues with Avalon GloboCare Corp.'s continued listing on a stock exchange, which could significantly impact its stock's liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- Avalon GloboCare Corp. (company) — Registrant
- October 29, 2024 (date) — Date of earliest event reported
- November 1, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Freehold, NJ (location) — Principal executive offices
FAQ
What specific listing rule or standard has Avalon GloboCare Corp. failed to satisfy?
The filing does not specify the exact rule or standard that has not been met, only that a notice has been issued.
What is the exact date of the notice of delisting or failure to satisfy a continued listing rule?
The earliest event reported date is October 29, 2024, which is when the notice pertains to.
What is the company's primary business as indicated by its SIC code?
The company's SIC code is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Where are Avalon GloboCare Corp.'s principal executive offices located?
The principal executive offices are located at 4400 Route 9 South, Suite 3100, Freehold, NJ 07728.
What is the Commission File Number for Avalon GloboCare Corp.?
The Commission File Number for Avalon GloboCare Corp. is 001-38728.
Filing Stats: 573 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2024-11-01 17:00:08
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ALBT The Nasdaq Capital M
Filing Documents
- ea021963001-8k_avalonglobo.htm (8-K) — 23KB
- 0001213900-24-093565.txt ( ) — 193KB
- albt-20241029.xsd (EX-101.SCH) — 3KB
- albt-20241029_lab.xml (EX-101.LAB) — 33KB
- albt-20241029_pre.xml (EX-101.PRE) — 22KB
- ea021963001-8k_avalonglobo_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVALON GLOBOCARE CORP. Dated: November 1, 2024 By: /s/ Luisa Ingargiola Name: Luisa Ingargiola Title: Chief Financial Officer